Centogene receives delisting notice from Nasdaq

Centogene received a notice from Nasdaq indicating that the Nasdaq Hearings Panel has determined to delist Centogene’s common stock from Nasdaq. The notice indicates that Centogene remains noncompliant with Nasdaq Listing Rules which require a minimum $15M market value of publicly held shares. Suspension of trading in the company’s common stock on Nasdaq will be effective at the open of trading on August 8. The company may, within 15 calendar days from the date of the notice, request that Nasdaq review the decision, but the company does not intend to make such a request. The Company expects its common stock to commence trading on the OTC Markets at the open of trading on August 8 under the symbol “CNTGF.” The company has also applied to trade its common stock on the OTCQX Market and expects to commence trading of its common stock on the OTCQX in the coming weeks. The company continues to actively pursue a sale transaction pursuant to its announced strategic alternatives review process.